BG107371A - Лекарствено средство за невроза с тревожност или депресия и пиперазинови производни - Google Patents

Лекарствено средство за невроза с тревожност или депресия и пиперазинови производни Download PDF

Info

Publication number
BG107371A
BG107371A BG107371A BG10737102A BG107371A BG 107371 A BG107371 A BG 107371A BG 107371 A BG107371 A BG 107371A BG 10737102 A BG10737102 A BG 10737102A BG 107371 A BG107371 A BG 107371A
Authority
BG
Bulgaria
Prior art keywords
group
substituted
compound
hydrogen atom
phenyl
Prior art date
Application number
BG107371A
Other languages
Bulgarian (bg)
English (en)
Inventor
Atsuro Nakazato
Shigeyuki Chaki
Taketoshi Okubo
Shin-Ichi Ogawa
Takaaki Ishii
Original Assignee
Taisho Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co., Ltd filed Critical Taisho Pharmaceutical Co., Ltd
Publication of BG107371A publication Critical patent/BG107371A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG107371A 2000-06-27 2002-12-11 Лекарствено средство за невроза с тревожност или депресия и пиперазинови производни BG107371A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000192856 2000-06-27
PCT/JP2001/005524 WO2002000259A1 (fr) 2000-06-27 2001-06-27 Agent therapeutique contre l'anxiete nevrotique ou la depression et derive de piperazine

Publications (1)

Publication Number Publication Date
BG107371A true BG107371A (bg) 2003-08-29

Family

ID=18691931

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107371A BG107371A (bg) 2000-06-27 2002-12-11 Лекарствено средство за невроза с тревожност или депресия и пиперазинови производни

Country Status (22)

Country Link
US (1) US6949552B2 (ru)
EP (1) EP1295608A4 (ru)
JP (1) JP5002881B2 (ru)
KR (1) KR20030013470A (ru)
CN (1) CN1438897A (ru)
AU (2) AU2001266342B2 (ru)
BG (1) BG107371A (ru)
BR (1) BR0111976A (ru)
CA (1) CA2413506A1 (ru)
CZ (1) CZ20024165A3 (ru)
EA (2) EA200500087A1 (ru)
EE (1) EE200200717A (ru)
HR (1) HRP20030056A2 (ru)
HU (1) HUP0301719A2 (ru)
IL (1) IL153706A0 (ru)
MX (1) MXPA02012707A (ru)
NO (1) NO20026122L (ru)
NZ (1) NZ523800A (ru)
PL (1) PL360286A1 (ru)
SK (1) SK18322002A3 (ru)
WO (1) WO2002000259A1 (ru)
ZA (1) ZA200210386B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200500087A1 (ru) 2000-06-27 2005-06-30 Тайсо Фармасьютикал Ко., Лтд. Производные пиперазина
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
AU2002331064B2 (en) 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7655658B2 (en) 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
EP1468990A4 (en) * 2001-12-21 2006-01-04 Taisho Pharmaceutical Co Ltd piperazine derivative
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en) * 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
JP5259181B2 (ja) * 2005-04-04 2013-08-07 武田薬品工業株式会社 うつ病または不安神経症の予防または治療剤
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
WO2008039863A2 (en) * 2006-09-27 2008-04-03 Braincells, Inc. Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders
EP2072050A1 (en) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Compounds with anti-emetic effect
TW201113274A (en) 2009-09-07 2011-04-16 Vifor Int Ag Novel ethanediamine hepcidine antagonists
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
CA2825098C (en) 2011-01-27 2020-03-10 Universite De Montreal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1317053A (fr) 1961-03-17 1963-02-01 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la pipérazine, et procédé de préparation
CA918659A (en) 1969-07-31 1973-01-09 Yoshitomi Pharmaceutical Industries 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines
FR2601364B1 (fr) * 1986-07-09 1988-10-21 Adir Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9021453D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
JPH0641071A (ja) * 1991-09-06 1994-02-15 Taisho Pharmaceut Co Ltd インドール酢酸エステル誘導体
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9700620D0 (sv) * 1997-02-21 1997-02-21 Wapharm Ab Cykliska peptider med selektivitet för MSH-receptor subtyper
WO1999064002A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
EA200500087A1 (ru) 2000-06-27 2005-06-30 Тайсо Фармасьютикал Ко., Лтд. Производные пиперазина

Also Published As

Publication number Publication date
CN1438897A (zh) 2003-08-27
HRP20030056A2 (en) 2005-02-28
EA200300071A1 (ru) 2003-06-26
EA005737B1 (ru) 2005-06-30
NZ523800A (en) 2005-02-25
AU6634201A (en) 2002-01-08
EP1295608A1 (en) 2003-03-26
CZ20024165A3 (cs) 2004-03-17
CA2413506A1 (en) 2002-12-20
KR20030013470A (ko) 2003-02-14
AU2001266342B2 (en) 2005-01-27
EE200200717A (et) 2004-08-16
WO2002000259A1 (fr) 2002-01-03
BR0111976A (pt) 2003-12-09
EP1295608A4 (en) 2004-03-31
US20030186992A1 (en) 2003-10-02
SK18322002A3 (sk) 2003-09-11
US6949552B2 (en) 2005-09-27
ZA200210386B (en) 2004-02-10
EA200500087A1 (ru) 2005-06-30
MXPA02012707A (es) 2003-04-25
HUP0301719A2 (hu) 2003-09-29
NO20026122D0 (no) 2002-12-19
NO20026122L (no) 2003-02-25
PL360286A1 (en) 2004-09-06
IL153706A0 (en) 2003-07-06
JP5002881B2 (ja) 2012-08-15

Similar Documents

Publication Publication Date Title
BG107371A (bg) Лекарствено средство за невроза с тревожност или депресия и пиперазинови производни
FI115769B (fi) Uudet piperidiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
US6410792B1 (en) Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
US7320989B2 (en) Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
EP2262784B1 (en) Inhibitors of the chemokine receptor cxcr3
CZ20012657A3 (cs) Piperidinové, tetrahydropyridinové a piperazinové deriváty
WO2001025228A1 (fr) Derives d'amines
SK15852000A3 (sk) Derivát 1-[(1-substituovaného-4-piperidinyl)metyl]-4-piperidínu, spôsob jeho prípravy, farmaceutický prípravok obsahujúci tento derivát a medziprodukt tohto derivátu
KR20080075236A (ko) N-[페닐(피페리딘-2-일)메틸]벤즈아미드의 유도체, 그의제조 방법 및 치료법에서의 그의 용도
SK188399A3 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
CZ20022581A3 (cs) 1,3-disubstituované pyrrolidiny, způsob jejich přípravy, jejich pouľití a farmaceutický prostředek, který je obsahuje
EP1294699B1 (en) Modulators of tnf- alpha signalling
WO2014136305A1 (ja) モルヒナン誘導体
CN113292485B (zh) 苄基哌嗪脲类trpv1拮抗和mor激动双靶点药物及制备方法和应用
JP6173693B2 (ja) アリールピペラジンオピオイド受容体アンタゴニスト
RU2007125691A (ru) Бенздиоксановые производные пиперазина с комбинацией сродства к допаминовым-d2 рецепторам и участкам обратного захвата серотонина
US5523305A (en) Tachykinin receptor antagonists, isoquinolones and their production
US20050282816A1 (en) Pyrazinylmethyl lactam derivatives
JPH07133273A (ja) 光学活性イミダゾリジノン誘導体とその製造方法
US11787787B2 (en) Delta-opioid receptor agonists
JP2006513151A (ja) 4−アミノピペリジン誘導体、その製造方法及び医薬品としての使用
US7049307B2 (en) Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
JP2001131149A (ja) 選択的セロトニン再取り込み阻害剤
JPH037229A (ja) 脳神経機能改善剤
JP2011529482A (ja) ピロリジニル−アルキル−アミド誘導体、これらの調製およびccr3受容体リガンドとしてのこれらの治療用途